Presentation
Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous MSC-NTF cells in progressive multiple sclerosis
Conference presentation of the Phase 2 open-label study of repeat intrathecal administration of autologous MSC-NTF cells in progressive multiple sclerosis.
Citation details
- Presented at
- 2019 Annual CMSC Meeting
- Published
- Type
- Presentation
- Topic
- Progressive Multiple Sclerosis